Pelthos Therapeutics (PTHS) Gross Margin (2025)
Pelthos Therapeutics has reported Gross Margin over the past 1 years, most recently at 89.87% for Q4 2025.
Pelthos Therapeutics has reported Gross Margin over the past 1 years, most recently at 89.87% for Q4 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month